| 翻訳と辞書 |
Diosynth
Diosynth, or Fujifilm Diosynth Biotechnologies, is a company that develops and offers manufacturing processes for active ingredients for pharmaceutical companies all over the world.
== History ==
The company started in Oss, Netherlands〔(【引用サイトリンク】title=Diosynth BV )〕 in 1923 with the extraction of insulin from bovine pancreas, and porcine insulin extraction in 1930, both of which are still part of their main products.〔(【引用サイトリンク】title=Diosynth Company History )〕〔(【引用サイトリンク】title=Diosynth-Usine Saint Charles, France-Insulin Extraction Plant )〕 In January 2005, the company became a part of Organon, one of its sister companies in the Akzo Nobel pharma group. Along with its sister companies Organon and Intervet were sold to Schering-Plough in March 2007 by Akzo Nobel. Following the mergers of Schering-Plough with Merck & Co. (MSD) in March 9, 2009, the company was part of the MSD Nutritionals products company, belonging to the MSD group.〔Communication from one employee, no reference found on the web site, but a presentation of (Diosynth france ) company(modified april.2012)〕 In April 2011, the company was sold to Fujifilm and Fujifilm Diosynth Biotechnologies was formed.〔(【引用サイトリンク】title=Company History )〕
On December 18, 2014, Fujifilm Diosynth Biotechnologies acquired Kalon Biotherapeutic Technologies in College Station, TX, which became Fujifilm Diosynth Biotechnologies Texas, LLC.〔(【引用サイトリンク】title=Fujifilm Completes Acquisition of Kalon Biotherapeutics )〕
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Diosynth」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|